Cartography Biosciencesh secures $57 million in Series A funding

Cartography Biosciencesh is a precision medicine service provider that aims to create treatments using the first comprehensive antigenic atlas of immuno-oncology targets. Cartography Biosciences recently announced that it has raised $57 million in Series A financing led by 8VC, with participation from existing investors Andreessen Horowitz (a16z) and Wing VC, and new investors Catalio Capital Management, ARTIS Ventures, Alexandria Venture Investments, AME Cloud Ventures and Gainels participated in this round of financing.

This article is reproduced from:
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment

Your email address will not be published.